US Stock MarketDetailed Quotes
APRE Aprea Therapeutics
- 3.960
- +0.100+2.59%
Close Jul 26 16:00 ET
21.50MMarket Cap-1207P/E (TTM)
3.960High3.800Low3.76KVolume3.840Open3.860Pre Close14.68KTurnover0.09%Turnover RatioLossP/E (Static)5.43MShares8.84752wk High0.74P/B15.90MFloat Cap2.95052wk Low--Dividend TTM4.01MShs Float1062.200Historical High--Div YieldTTM4.15%Amplitude2.780Historical Low3.909Avg Price1Lot Size
Aprea Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 4.43%32.37M | -24.94%21.61M | -24.94%21.61M | -23.43%25.35M | -29.13%27.69M | -34.95%31M | -45.76%28.79M | -45.76%28.79M | -46.10%33.11M | -44.04%39.06M |
| -Cash and cash equivalents | 4.43%32.37M | -24.94%21.61M | -24.94%21.61M | -23.43%25.35M | -29.13%27.69M | -34.95%31M | -45.76%28.79M | -45.76%28.79M | -46.10%33.11M | -44.04%39.06M |
| Other current assets | -31.67%698.86K | -33.11%914.28K | -33.11%914.28K | -20.74%286.26K | -31.92%953.67K | -57.26%1.02M | -61.04%1.37M | -61.04%1.37M | -51.90%361.18K | -6.26%1.4M |
| Total current assets | 3.28%33.07M | -25.31%22.52M | -25.31%22.52M | -23.40%25.64M | -29.22%28.64M | -36.02%32.02M | -46.71%30.15M | -46.71%30.15M | -46.17%33.47M | -43.25%40.46M |
| Non current assets | ||||||||||
| Net PPE | 4,616.68%90.18K | 3,707.07%88.36K | 3,707.07%88.36K | -27.43%86.2K | -99.12%1.69K | -99.27%1.91K | -98.89%2.32K | -98.89%2.32K | -56.99%118.77K | -13.88%191.23K |
| -Gross PPE | ---- | 205.09%138.48K | 205.09%138.48K | ---- | ---- | ---- | -86.11%45.39K | -86.11%45.39K | -56.99%118.77K | -13.88%191.23K |
| -Accumulated depreciation | ---- | -16.37%-50.12K | -16.37%-50.12K | ---- | ---- | ---- | 63.19%-43.07K | 63.19%-43.07K | ---- | ---- |
| Other non current assets | --40.99K | --40.72K | --40.72K | 37.81%40.45K | 36.86%40.18K | ---- | ---- | ---- | -0.08%29.35K | -0.07%29.36K |
| Total non current assets | 6,760.30%131.17K | 5,461.35%129.08K | 5,461.35%129.08K | -14.50%126.65K | -81.02%41.87K | -99.35%1.91K | -99.03%2.32K | -99.03%2.32K | -51.52%148.13K | -12.27%220.58K |
| Total assets | 3.68%33.2M | -24.89%22.65M | -24.89%22.65M | -23.36%25.77M | -29.50%28.68M | -36.39%32.02M | -46.93%30.16M | -46.93%30.16M | -46.19%33.62M | -43.14%40.68M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 59.61%1.32M | 98.20%1.67M | 98.20%1.67M | -24.08%862.55K | -71.65%1.13M | -58.45%826.03K | -52.47%842.75K | -52.47%842.75K | -55.42%1.14M | 68.96%3.99M |
| -accounts payable | 59.61%1.32M | 98.20%1.67M | 98.20%1.67M | -24.08%862.55K | -71.65%1.13M | -58.45%826.03K | -52.47%842.75K | -52.47%842.75K | -55.42%1.14M | 68.96%3.99M |
| Current accrued expenses | -27.48%1.21M | 21.76%1.17M | 21.76%1.17M | 91.89%2.26M | -15.41%1.54M | -57.49%1.67M | -75.59%960.36K | -75.59%960.36K | -77.11%1.18M | -74.52%1.83M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.65%110.55K | -5.07%189.12K |
| -Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.65%110.55K | -5.07%189.12K |
| Current deferred liabilities | --148.41K | --528.97K | --528.97K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Current liabilities | -29.86%2.97M | 37.00%4.39M | 37.00%4.39M | 4.20%4.17M | -48.59%3.95M | -37.09%4.23M | -56.25%3.2M | -56.25%3.2M | -55.77%4M | -27.49%7.68M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| -Long term capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Preferred securities outside stock equity | 0.00%1.31M | 0.00%1.31M | 0.00%1.31M | -56.28%1.31M | -98.09%1.31M | --1.31M | --1.31M | --1.31M | --3M | --68.78M |
| Total non current liabilities | 0.00%1.31M | 0.00%1.31M | 0.00%1.31M | -56.28%1.31M | -98.09%1.31M | 4,572.19%1.31M | --1.31M | --1.31M | 9,971.33%3M | --68.78M |
| Total liabilities | -22.79%4.28M | 26.25%5.7M | 26.25%5.7M | -21.72%5.48M | -93.12%5.26M | -17.93%5.54M | -38.33%4.51M | -38.33%4.51M | -22.86%7M | 621.47%76.46M |
| Shareholders'equity | ||||||||||
| Share capital | 45.54%5.43K | 40.72%3.74K | 40.72%3.74K | -92.85%3.74K | -84.06%3.73K | -83.02%3.73K | 143.13%2.66K | 143.13%2.66K | 144.56%52.24K | 10.45%23.4K |
| -common stock | 45.54%5.43K | 40.72%3.74K | 40.72%3.74K | -92.85%3.74K | -84.06%3.73K | -83.02%3.73K | 143.13%2.66K | 143.13%2.66K | 144.56%52.24K | 10.45%23.4K |
| Retained earnings | -4.26%-310.89M | -4.86%-308.08M | -4.86%-308.08M | -4.56%-304.64M | -4.91%-301.44M | -57.71%-298.18M | -62.20%-293.8M | -62.20%-293.8M | -68.04%-291.35M | -75.28%-287.33M |
| Paid-in capital | 4.54%350.44M | 1.69%335.64M | 1.69%335.64M | 2.25%335.56M | 28.15%335.49M | 37.91%335.22M | 36.96%330.06M | 36.96%330.06M | 38.33%328.17M | 11.35%261.8M |
| Gains losses not affecting retained earnings | -0.61%-10.63M | 0.11%-10.61M | 0.11%-10.61M | -3.86%-10.64M | -3.59%-10.63M | -1.31%-10.56M | -2.55%-10.62M | -2.55%-10.62M | 2.05%-10.24M | -0.19%-10.27M |
| Total stockholders'equity | 9.22%28.92M | -33.89%16.95M | -33.89%16.95M | -23.80%20.29M | 165.46%23.42M | -39.25%26.48M | -48.20%25.64M | -48.20%25.64M | -50.15%26.63M | -158.70%-35.78M |
| Total equity | 9.22%28.92M | -33.89%16.95M | -33.89%16.95M | -23.80%20.29M | 165.46%23.42M | -39.25%26.48M | -48.20%25.64M | -48.20%25.64M | -50.15%26.63M | -158.70%-35.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg